SERA PROGNOSTICS, INC. - 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Sera Prognostics, Inc. on June 5, 2025. The meeting was conducted via live audio webcast. As of the record date of April 9, 2025, there were 36,701,381 shares of Class A common stock issued and outstanding eligible to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
A quorum of 24,314,265 shares (66.2% of eligible shares) was present at the meeting. Stockholders approved the following matters:
- Election of Directors: Jane F. Barlow, M.D. and Mansoor Raza Mirza, M.D. were elected as Class I directors for a three-year term.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. Detailed descriptions of the matters voted upon are referenced in the definitive proxy statement on Schedule 14A filed on April 23, 2025.
Investor Verification Checklist
- Verify the full voting breakdown for the election of Jane F. Barlow, M.D. and Mansoor Raza Mirza, M.D., including the significant number of shares withheld (approx. 4.9 million each).
- Review the definitive proxy statement (Schedule 14A) filed on April 23, 2025, for detailed biographies of the new directors and the rationale for the auditor appointment.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.